# High-dose Intravenous Vitamin C in Patients With Septic Shock

> **NCT04796636** · PHASE1 · UNKNOWN · sponsor: **Melbourne Health** · enrollment: 30 (estimated)

## Conditions studied

- Sepsis, Severe
- Septic Shock

## Interventions

- **DRUG:** Sodium Ascorbate

## Key facts

- **NCT ID:** NCT04796636
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-27
- **Primary completion:** 2023-09-22
- **Final completion:** 2023-12-22
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04796636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04796636, "High-dose Intravenous Vitamin C in Patients With Septic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04796636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*